AdaptHealth Corp. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
AdaptHealth Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q4 2024.
  • AdaptHealth Corp. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $4.28M, a 18.8% decline year-over-year.
  • AdaptHealth Corp. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $14.9M, a 33.8% decline year-over-year.
  • AdaptHealth Corp. annual Share-based Payment Arrangement, Expense for 2024 was $14.9M, a 33.8% decline from 2023.
  • AdaptHealth Corp. annual Share-based Payment Arrangement, Expense for 2023 was $22.5M, a 0.32% increase from 2022.
  • AdaptHealth Corp. annual Share-based Payment Arrangement, Expense for 2022 was $22.4M, a 11.6% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $14.9M $4.28M -$988K -18.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $15.9M $900K -$3.6M -80% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $19.5M $5.2M -$1.6M -23.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $21.1M $4.5M -$1.4M -23.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $22.5M $5.27M -$329K -5.88% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $22.8M $4.5M -$1.1M -19.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $23.9M $6.8M +$1.1M +19.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $22.8M $5.9M +$400K +7.27% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $22.4M $5.6M +$1.67M +42.7% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 $20.7M $5.6M +$200K +3.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $20.5M $5.7M -$1.7M -23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $22.2M $5.5M -$3.1M -36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $25.3M $3.92M -$3.78M -49.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $29.1M $5.4M -$100K -1.82% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $29.2M $7.4M +$4.1M +124% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $25.1M $8.6M +$6.4M +291% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $18.7M $7.7M +$2.42M +45.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $16.3M $5.5M +$5.1M +1275% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $11.2M $3.3M +$3.1M +1550% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $8.08M $2.2M -$3.02M -57.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $11.1M $5.28M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $400K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $200K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $5.22M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.